Latest Beta amyloid Stories
On the heels of a study which found that copper could factor into the onset and progression of the neurodegenerative condition, a second group of scientists has published research suggesting that iron accumulation could be one of the core contributing factors leading to the onset of Alzheimer's Disease.
In patients with early Alzheimer's disease, disruptions in brain networks emerge about the same time as chemical markers of the disease appear in the spinal fluid.
An element that is essential to all living organisms could also be one of the primary environmental factors that can lead to the onset of Alzheimer’s disease, according to new research appearing in Monday’s edition of the journal Proceedings of the National Academy of Sciences.
A study funded in part by the Cure Alzheimer's Fund looking at the links between cholesterol and Alzheimer's brings researchers closer to identifying a drug to interrupt the disease process.
Though one might think the brains of people who develop Alzheimer's disease (AD) possess building blocks of the disease absent in healthy brains, for most sufferers, this is not true.
UCLA chemists and molecular biologists have for the first time used a "structure-based" approach to drug design to identify compounds with the potential to delay or treat Alzheimer's disease, and possibly Parkinson's, Lou Gehrig's disease and other degenerative disorders.
Researchers at Columbia University Medical Center recently discovered key molecular pathways in the brain that lead to late-onset Alzheimer's disease, the most common form of the disorder.
- Easily ashamed, having a strong sense of shame; modest; chaste.
- Of or pertaining to the external organs of generation.